Immunovia AB (publ) (IMMVF)
USD 0.07
(0.0%)
USD 0.07
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 98.68 Million SEK | -67.17% |
| 2022 | 300.58 Million SEK | -39.13% |
| 2021 | 493.8 Million SEK | -25.31% |
| 2020 | 661.17 Million SEK | 57.66% |
| 2019 | 419.36 Million SEK | -12.15% |
| 2018 | 477.38 Million SEK | 90.37% |
| 2017 | 250.76 Million SEK | -11.52% |
| 2016 | 283.4 Million SEK | 209.71% |
| 2015 | 91.5 Million SEK | 135.4% |
| 2014 | 38.87 Million SEK | 420.7% |
| 2013 | 7.46 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 71.02 Million SEK | -28.03% |
| 2024 Q2 | 58.26 Million SEK | -17.96% |
| 2023 Q3 | 149.59 Million SEK | -21.31% |
| 2023 FY | 98.68 Million SEK | -67.17% |
| 2023 Q2 | 190.1 Million SEK | -24.86% |
| 2023 Q1 | 253 Million SEK | -15.83% |
| 2023 Q4 | 98.68 Million SEK | -34.03% |
| 2022 Q3 | 360.79 Million SEK | -10.67% |
| 2022 FY | 300.58 Million SEK | -39.13% |
| 2022 Q1 | 449.54 Million SEK | -8.96% |
| 2022 Q2 | 403.89 Million SEK | -10.16% |
| 2022 Q4 | 300.58 Million SEK | -16.69% |
| 2021 Q1 | 635.68 Million SEK | -3.86% |
| 2021 FY | 493.8 Million SEK | -25.31% |
| 2021 Q4 | 493.8 Million SEK | -10.51% |
| 2021 Q3 | 551.79 Million SEK | -8.03% |
| 2021 Q2 | 599.98 Million SEK | -5.62% |
| 2020 Q3 | 697.08 Million SEK | -5.1% |
| 2020 Q1 | 392.28 Million SEK | -6.46% |
| 2020 Q4 | 661.17 Million SEK | -5.15% |
| 2020 FY | 661.17 Million SEK | 57.66% |
| 2020 Q2 | 734.55 Million SEK | 87.25% |
| 2019 Q1 | 490.75 Million SEK | 2.8% |
| 2019 Q4 | 419.36 Million SEK | -5.83% |
| 2019 Q2 | 461.57 Million SEK | -5.95% |
| 2019 FY | 419.36 Million SEK | -12.15% |
| 2019 Q3 | 445.34 Million SEK | -3.52% |
| 2018 Q4 | 477.38 Million SEK | -4.8% |
| 2018 FY | 477.38 Million SEK | 90.37% |
| 2018 Q3 | 501.42 Million SEK | -4.71% |
| 2018 Q1 | 233.76 Million SEK | -6.78% |
| 2018 Q2 | 526.2 Million SEK | 125.1% |
| 2017 Q2 | 268.54 Million SEK | -2.85% |
| 2017 FY | 250.76 Million SEK | -11.52% |
| 2017 Q4 | 250.76 Million SEK | -3.63% |
| 2017 Q3 | 260.2 Million SEK | -3.11% |
| 2017 Q1 | 276.43 Million SEK | -2.46% |
| 2016 Q2 | 84.32 Million SEK | 0.0% |
| 2016 FY | 283.4 Million SEK | 209.71% |
| 2016 Q1 | - SEK | -100.0% |
| 2016 Q4 | 283.4 Million SEK | 0.0% |
| 2015 Q1 | 37.99 Million SEK | -2.27% |
| 2015 Q2 | 37.99 Million SEK | 0.0% |
| 2015 Q4 | 91.5 Million SEK | 0.0% |
| 2015 Q3 | 91.5 Million SEK | 140.86% |
| 2015 FY | 91.5 Million SEK | 135.4% |
| 2014 Q1 | - SEK | 0.0% |
| 2014 Q4 | 38.87 Million SEK | 0.0% |
| 2014 Q3 | 38.87 Million SEK | 0.0% |
| 2014 FY | 38.87 Million SEK | 420.7% |
| 2013 FY | 7.46 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -7676.281% |
| Arrayit Corporation | 1 Million USD | -9764.263% |
| Atlantic International Corp. | 4.43 Million USD | -2124.368% |
| Biocept, Inc. | 30.87 Million USD | -219.635% |
| Bioqual, Inc. | 56.58 Million USD | -74.385% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -42447.385% |
| DermTech, Inc. | 121.93 Million USD | 19.067% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 97.642% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | -455.084% |
| iMD Companies, Inc. | 190.13 Thousand USD | -51799.946% |
| IDenta Corp. | 1.52 Million USD | -6352.796% |
| Interpace Biosciences, Inc. | 13.02 Million USD | -657.86% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | -1095.856% |
| InVitro International | 1.53 Million USD | -6332.891% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | -267.691% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -4268109.343% |
| Medical Imaging Corp. | 4.19 Million USD | -2254.241% |
| NovelStem International Corp. | 2.25 Million USD | -4276.979% |
| Optigenex Inc. | 1.88 Million USD | -5125.945% |
| PharmChem, Inc. | 2.76 Million USD | -3468.212% |
| Proteome Sciences plc | 14.58 Million USD | -576.544% |
| Response Genetics, Inc | 48.88 Million USD | -101.868% |
| Rennova Health, Inc. | 20.57 Million USD | -379.668% |
| RushNet, Inc. | 6.04 Million USD | -1531.737% |
| ScreenPro Security Inc. | 1.26 Million USD | -7723.387% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -20788.272% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -13984.167% |
| Todos Medical Ltd. | 15.26 Million USD | -546.368% |